Rockwell Medical (RMTI) Interest Coverage Ratio (2010 - 2026)
Rockwell Medical (RMTI) posted Interest Coverage Ratio of 0.26 for Q1 2026, up 68.6% on a QoQ basis from 0.82 in Q4 2025, and up 89.59% year-over-year from 0.14 in Q1 2025.
Rockwell Medical (RMTI) Interest Coverage Ratio (2010 - 2026) Analysis & Trends
Rockwell Medical's Interest Coverage Ratio history runs 17 years deep, the most recent figure standing at 0.26 for Q1 2026.
- Quarterly Interest Coverage Ratio rose 89.59% year-over-year to 0.26 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.83 (down 180.49% YoY) and the FY2025 annual result came in at 0.68, down 9639.49% from the prior year.
- Interest Coverage Ratio was 0.26 for Q1 2026 at Rockwell Medical, up from 0.82 in the prior quarter.
- Across five years, Interest Coverage Ratio topped out at 4.31 in Q3 2024 and bottomed at 12.27 in Q1 2022.
- A 5-year average of 3.19 and a median of 2.87 in 2025 frame the typical range for Interest Coverage Ratio.
- Peak annual rise in Interest Coverage Ratio reached 214.44% in 2024, while the deepest fall reached 350.44% in 2024.
- Rockwell Medical's Interest Coverage Ratio stood at 4.48 in 2022, then jumped by 91.1% to 0.4 in 2023, then plunged by 350.44% to 1.8 in 2024, then soared by 54.49% to 0.82 in 2025, then jumped by 68.6% to 0.26 in 2026.
- Business Quant data shows RMTI's Interest Coverage Ratio at 0.26 in Q1 2026, 0.82 in Q4 2025, and 2.87 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 13.44 |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -2.81 |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 0.18 |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -0.07 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 0.33 |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 5.11 |
| 10 | Rockwell Medical | 25.77 Mn | 1.88 Mn | 2.90 Mn | -0.26 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.26 |
| Dec 31, 2025 | -0.82 |
| Sep 30, 2025 | -2.87 |
| Jun 30, 2025 | -1.03 |
| Mar 31, 2025 | -2.46 |
| Dec 31, 2024 | -1.80 |
| Sep 30, 2024 | 4.31 |
| Jun 30, 2024 | 1.21 |
| Mar 31, 2024 | -3.03 |
| Dec 31, 2023 | -0.40 |
| Sep 30, 2023 | -3.77 |
| Jun 30, 2023 | -6.19 |
| Mar 31, 2023 | -3.37 |
| Dec 31, 2022 | -4.48 |
| Sep 30, 2022 | -7.79 |
| Jun 30, 2022 | -9.24 |
| Mar 31, 2022 | -12.27 |
| Dec 31, 2021 | -8.02 |
| Sep 30, 2021 | -11.45 |
| Jun 30, 2021 | -13.42 |